Date Filer Filing Type Shares Traded Price Total Held
Jan 22, 2021
Chief Financial Officer
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,000 $6.00 8,000
Sep 03, 2020
Chief Medical Officer
Form 3 Initial Statement of Beneficial Ownership of Securities -- -- --
Sep 03, 2020
Chief Financial Officer
Form 3 Initial Statement of Beneficial Ownership of Securities -- -- --
Sep 01, 2020
Chief Medical Officer
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 300,000
Sep 01, 2020
Chief Medical Officer
Form 4/A Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 300,000
Sep 01, 2020
Chief Financial Officer
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 350,000 -- 350,000
Sep 01, 2020
Chief Financial Officer
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 225,000 -- 225,000
Jun 30, 2020
Director
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 44,470 -- 44,470
Jun 30, 2020
Director
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 44,470 -- 44,470
Jun 30, 2020
Director
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 44,470 -- 44,470

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.